DK3099314T3 - Tolerogene sammensætninger og anvendelser deraf - Google Patents

Tolerogene sammensætninger og anvendelser deraf Download PDF

Info

Publication number
DK3099314T3
DK3099314T3 DK15708316.3T DK15708316T DK3099314T3 DK 3099314 T3 DK3099314 T3 DK 3099314T3 DK 15708316 T DK15708316 T DK 15708316T DK 3099314 T3 DK3099314 T3 DK 3099314T3
Authority
DK
Denmark
Prior art keywords
tolerogenic compositions
tolerogenic
compositions
Prior art date
Application number
DK15708316.3T
Other languages
Danish (da)
English (en)
Inventor
Anne Mueller
Daniela Engler-Anders
Christian Taube
Original Assignee
Univ Zuerich
Leiden Univ Medical Center Lumc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich, Leiden Univ Medical Center Lumc filed Critical Univ Zuerich
Application granted granted Critical
Publication of DK3099314T3 publication Critical patent/DK3099314T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15708316.3T 2014-01-31 2015-01-30 Tolerogene sammensætninger og anvendelser deraf DK3099314T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14153365.3A EP2902037A1 (en) 2014-01-31 2014-01-31 Tolerogenic compositions comprising and uses thereof
PCT/IB2015/050703 WO2015114575A1 (en) 2014-01-31 2015-01-30 Tolerogenic compositions comprising and uses thereof

Publications (1)

Publication Number Publication Date
DK3099314T3 true DK3099314T3 (da) 2020-07-20

Family

ID=50028895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15708316.3T DK3099314T3 (da) 2014-01-31 2015-01-30 Tolerogene sammensætninger og anvendelser deraf

Country Status (8)

Country Link
US (1) US9999660B2 (enExample)
EP (2) EP2902037A1 (enExample)
JP (1) JP6563937B2 (enExample)
AU (1) AU2015212357B2 (enExample)
CA (1) CA2943149C (enExample)
DK (1) DK3099314T3 (enExample)
ES (1) ES2806773T3 (enExample)
WO (1) WO2015114575A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166986B2 (en) 2014-01-31 2021-11-09 Universitat Zurich Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
EP4669337A1 (en) * 2023-09-26 2025-12-31 Atopia Therapeutics Sa USEFUL AGENTS FOR THE PREVENTION OR TREATMENT OF ALLERGIC AND INFAMMATORY DISORDERS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004017A2 (en) * 2000-07-07 2002-01-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for preparing oral vaccines
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
JP2004189730A (ja) * 2002-11-28 2004-07-08 Japan Science & Technology Agency 細胞死の抑制方法、細胞死抑制剤、及びその細胞死抑制剤を含む細胞死に起因する疾患の治療薬剤
US11166986B2 (en) 2014-01-31 2021-11-09 Universitat Zurich Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease

Also Published As

Publication number Publication date
EP2902037A1 (en) 2015-08-05
AU2015212357B2 (en) 2020-05-28
EP3099314B1 (en) 2020-04-22
EP3099314A1 (en) 2016-12-07
ES2806773T3 (es) 2021-02-18
US20170007683A1 (en) 2017-01-12
WO2015114575A1 (en) 2015-08-06
JP2017509597A (ja) 2017-04-06
US9999660B2 (en) 2018-06-19
CA2943149A1 (en) 2015-08-06
CA2943149C (en) 2022-07-12
AU2015212357A1 (en) 2016-08-18
JP6563937B2 (ja) 2019-08-21

Similar Documents

Publication Publication Date Title
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3169733T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3018183T3 (da) Halogenolefinbaseret sammensætning og anvendelse deraf
EP3205103C0 (en) INTER AND INTRA UNIFICATION BLOCK COPY
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3145493T3 (da) Fremgangsmåder og sammensætninger vedrørende exosomer
KR20180084891A (ko) 구조 조성물 및 방법
DK3096785T3 (da) Immunogene sammensætninger omfattende konjugerede kapsel-saccharid-antigener og anvendelser deraf
DK3157552T3 (da) Syntac-polypeptider og anvendelser deraf
IL250568A0 (en) Anti-methanogenic preparations and their uses
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
LT3102555T (lt) Junginių kompozicijos ir jų panaudojimas
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3494119T3 (da) Forbindelser og sammensætninger og anvendelser deraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3220750T3 (da) Oral rehydreringssammensætning og fremgangsmåder dertil
DK3209307T3 (da) Probiotiske og præbiotiske sammensætninger
DK3129007T3 (da) Vaccinesammensætninger
DK3098281T3 (da) Sammensætning omfattende hfc og hfo
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf